Vitamin C and Cancer: What the Evidence Really Shows
- , by SANUSq Research team
- 8 min reading time
"High-dose vitamin C kills cancer cells" is one of the most persistent claims in natural health. Like many such claims, it contains a real grain of science wrapped in a great deal of overstatement. Here's what the evidence on vitamin C and cancer actually shows — and what it doesn't.
Where the claim comes from
The idea isn't pulled from nowhere. In laboratory studies, vitamin C (ascorbate) at very high concentrations behaves quite differently from the vitamin in your orange juice: at those levels it can act as a pro-oxidant, generating hydrogen peroxide that cancer cells — which are often less able to mop it up than healthy cells — find selectively toxic. In cell cultures and animal models, this can slow or kill certain cancer cells. That's the genuine science behind the headline — but it is worth being exact about what it is: the vitamin C anti-cancer properties reported in those papers are laboratory properties, seen at concentrations no capsule can produce.
Researchers have shown that pharmacological (very high) concentrations of ascorbate generate hydrogen peroxide that is preferentially toxic to tumour cells, because many cancer cells are less able to detoxify it — a mechanism only achievable at blood levels far above what any oral dose can produce (reviewed by Ngo et al.).
Notice that this is the opposite of vitamin C's everyday role as an antioxidant — a neat illustration of how dose changes everything. At the modest levels you get from food or a supplement, vitamin C is an antioxidant supporting normal health; only at the extreme concentrations of an infusion does the pro-oxidant, cancer-cell-stressing effect appear.
The crucial catch: oral vs intravenous
That last point is everything. The cancer-killing effect requires blood concentrations of vitamin C that cannot be reached by swallowing it — the gut tightly limits how much oral vitamin C enters the bloodstream, so no capsule or powder, however "high-dose", gets anywhere near the levels used in those lab studies. Those concentrations are only achievable by intravenous (IV) infusion, which bypasses the gut entirely. So when you read that "high-dose vitamin C kills cancer cells", the honest translation is: intravenous pharmacological ascorbate does something interesting in the laboratory. It is not a claim about the vitamin C you can buy and take at home.
What happened when it was tested in people
This distinction has real history. In the 1970s, Linus Pauling and Ewan Cameron reported that vitamin C helped cancer patients. But when the Mayo Clinic ran rigorous randomised trials, they used oral vitamin C — and found nothing.
In a double-blind randomised trial, 10 g/day of oral vitamin C showed no advantage over placebo for either disease progression or survival in patients with advanced cancer (Moertel et al., 1985). This, and an earlier similar trial, led to oral vitamin C being written off as a cancer treatment — and, crucially, the reason is now thought to be the route: oral simply can't reach the active concentrations.
So where does the research stand now?
Interest has revived — but specifically around intravenous vitamin C, and specifically as a possible complement to conventional treatment, not a replacement. Early-phase trials are exploring whether IV ascorbate can improve quality of life, reduce side effects, or enhance chemotherapy and radiotherapy in certain cancers. The results so far are mixed and preliminary; IV vitamin C remains investigational, something being studied in trials rather than an established therapy. It is not a proven cancer treatment, and it should only ever be used within proper medical oversight.
It also isn't free of practical risks: IV vitamin C must be medically supervised, isn't suitable for everyone (people with conditions such as G6PD deficiency or kidney impairment can be harmed by high doses), and can interfere with some lab tests and potentially some treatments. That is precisely why it belongs in a clinical trial or oncology setting rather than a self-directed regimen.
Vitamin C cancer prevention: what about your diet?
Here the picture is gentler and more positive. A diet rich in vitamin C — from fruit and vegetables — is associated in observational studies with a lower risk of some cancers, most likely as part of the broader benefit of an antioxidant-rich, plant-heavy diet. That's a good reason to eat plenty of vitamin-C-rich foods for general health and prevention. It is also the only part of the vitamin C cancer prevention story with population evidence behind it, and even there the credit most likely belongs to the whole diet rather than to the vitamin alone. But "linked with lower risk in population studies" is a world away from "treats cancer", and the two shouldn't be confused.
Put simply: eating your vitamin C is a sound part of a cancer-protective lifestyle; it is not, and should not be sold as, a way to treat a cancer that already exists.
The honest bottom line
Vitamin C is essential, a good dietary intake supports overall health, and IV ascorbate is a legitimate area of ongoing cancer research. What vitamin C is not is a home cancer remedy: there is no high-dose vitamin C cancer treatment, full stop, and taking high-dose oral vitamin C will not treat cancer — the rigorous trials of oral dosing found no benefit, and no one facing cancer should rely on it in place of proven medical care. If you're interested in IV vitamin C as a complement to treatment, that's a conversation to have with your oncology team — not a decision to make from a supplement label.
Believe the science, in other words — all of it, including the parts that temper the headline.
Frequently asked questions
Does high-dose vitamin C kill cancer cells?
At very high (pharmacological) concentrations, ascorbate can kill certain cancer cells in the laboratory by generating hydrogen peroxide. But those concentrations can only be reached by intravenous infusion — not by any oral dose — and this remains a laboratory and early-trial finding, not a proven treatment in people.
Can I treat cancer with vitamin C tablets?
No. Oral vitamin C, even in high doses, cannot reach the blood levels needed for the anticancer effect seen in the lab, and randomised trials of high-dose oral vitamin C in cancer patients found no benefit. Oral vitamin C is valuable for nutrition and general health, not as a cancer therapy.
Why did the Mayo Clinic trials find no benefit?
Because they used oral vitamin C. It's now understood that oral dosing can't achieve the very high blood concentrations required — only intravenous infusion can — which is why the earlier oral trials were negative and interest has since shifted to IV ascorbate.
Is intravenous vitamin C a cancer cure?
No — it's investigational. IV vitamin C is being studied, mainly as a possible complement to standard treatment (for example to ease side effects or support quality of life), with mixed, preliminary results. It is not an established or proven cancer therapy and should only be used under medical supervision within that context.
Can vitamin C prevent cancer?
Not in the way the headlines suggest. A vitamin-C-rich, plant-heavy diet is linked in observational studies with lower risk of some cancers — a good reason to eat plenty of fruit and vegetables for general health — but an association across populations is not proof that the vitamin itself does the preventing, and no vitamin C supplement has been shown to prevent cancer. That's about prevention as part of an overall healthy diet, though, and is very different from treating an existing cancer.
The best evidence-based advice remains the least glamorous: eat a varied, plant-rich diet, don't smoke, and follow proven screening and treatment. Vitamin C fits into that picture as good nutrition — not as a shortcut around it.
References
- Moertel CG, Fleming TR, Creagan ET, Rubin J, O'Connell MJ, Ames MM. High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy: a randomized double-blind comparison. New England Journal of Medicine. 1985;312(3):137–141. PMID 3880867
- Vissers MCM, Das AB. Potential Mechanisms of Action for Vitamin C in Cancer: Reviewing the Evidence. Front Physiol. 2018;9:809. Review, PMC6037948
Read more on the blog
Watch on YouTube
Explore more on our channel, @SANUSqHealthSupplements.
We wish you good health on your terms.
The team at SANUSq.
PS. Curious what's currently on offer? Take a look at our latest promotions.
The health information in this article is provided for educational purposes only. Consult your healthcare professional before making any medical decisions.
Regulatory Notice
The information on our websites, blogs, and emails is provided for informational purposes only and has not been evaluated by the EMA, EFSA, or FDA. It is not intended to replace medical advice provided by your healthcare professional, and is not intended to diagnose, treat, cure, or prevent any disease. Our products are intended for adults aged 18 and over. While the vitamins and supplements mentioned may offer various health benefits, supplements and dietary changes should be considered part of an overall health plan and not a substitute for professional medical treatment. Only a qualified healthcare professional can provide personalized advice and treatment plans based on your individual health needs and medical history; you should consult your healthcare professional before taking any product(s) if you are pregnant or breastfeeding.